The company reported fourth-quarter and full-year 2025 financial results, highlighting growth in its dental business.
Solventum has released its financial results for the fourth quarter and full year ended December 31, 2025, reporting an 8.6% increase in net sales for its dental solutions segment in the fourth quarter.
Dental Segment Performance
The dental solutions segment posted net sales of $343 million for the fourth quarter of 2025, an increase from $315 million in the same period of 2024. The segment saw organic growth of 5.9% for the quarter.
For the full year, the dental solutions business grew 4.2%, with net sales reaching $1.349 billion compared to $1.295 billion in 2024. The segment’s organic growth for the full year was 3.3%.
Overall Company Results and Outlook
Overall, Solventum reported total net sales of $1.998 billion for the fourth quarter. For the full year 2025, total company net sales were $8.325 billion, an increase of 0.9% over 2024. The company noted that organic sales growth in the quarter was driven by positive performance from all segments, including dental solutions.
“Solventum’s fourth quarter results reflect another quarter of solid performance resulting in full year 2025 results ahead of our expectations for sales and EPS,” says Bryan Hanson, chief executive officer of Solventum, in a release.
The company also introduced its financial guidance for the full year 2026.
Photo: ID 108949137 © Komgrit Pradissagul | Dreamstime.com
